Source:http://linkedlifedata.com/resource/pubmed/id/20522379
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
2010-6-4
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jun
|
| pubmed:issn |
1474-5488
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
11
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
513-4
|
| pubmed:dateRevised |
2010-9-13
|
| pubmed:meshHeading |
pubmed-meshheading:20522379-Antibodies, Monoclonal,
pubmed-meshheading:20522379-Antineoplastic Agents,
pubmed-meshheading:20522379-Bone Neoplasms,
pubmed-meshheading:20522379-Giant Cell Tumor of Bone,
pubmed-meshheading:20522379-Humans,
pubmed-meshheading:20522379-Jaw Diseases,
pubmed-meshheading:20522379-Osteonecrosis,
pubmed-meshheading:20522379-RANK Ligand
|
| pubmed:year |
2010
|
| pubmed:articleTitle |
Safety and efficacy of denosumab in giant-cell tumour of bone.
|
| pubmed:publicationType |
Letter,
Comment
|